Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552695 · ClinicalTrials.gov registry record · Phase 2
Lidocaine Patches Prior to Intravenous Insertion
A Phase 2 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00552695 is a Phase 2 study that has completed, run by Stony Brook University. The registered enrollment target is 45 participants.
The verdict
NCT00552695, a Phase 2 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will determine whether application of a patch containing a topical anesthetic (numbing medicine) named lidocaine can reduce the pain of subsequent insertion of an intravenous catheter in Emergency Department patients.
Interventions
- DEVICE Placebo
- DEVICE Lidocaine tetracaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00552695
The ClinicalTrials.gov registry entry for NCT00552695 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00552695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00552695 about?
NCT00552695 is a clinical study titled "Lidocaine Patches Prior to Intravenous Insertion". This study will determine whether application of a patch containing a topical anesthetic (numbing medicine) named lidocaine can reduce the pain of subsequent insertion of an intravenous catheter in Emergency Department patients.
What is the current status of trial NCT00552695?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2007-08. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00552695?
The interventions under investigation include: Placebo (DEVICE), Lidocaine tetracaine (DEVICE).
Who is sponsoring clinical trial NCT00552695?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.